Enliven Therapeutics, Inc.
ELVN
37 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17 11:45 PM | ORBIMED ADVISORS LLC10% Owner | Sale | 281,408 | $45.02 | $12.7M | 7,388,902(I) | View → |
| Jun 17, 2026 | Jun 17 8:24 PM | Hohl Benjamin | Proposed Sale | 18,054 | $42.55 | $768.2K | — | View → |
| Jun 15, 2026 | Jun 16 1:23 AM | The Biotech Growth Trust PLC | Proposed Sale | 10,243 | $42.36 | $433.9K | — | View → |
| Jun 15, 2026 | Jun 16 1:21 AM | OrbiMed Private Investments VII, LP | Proposed Sale | 272,322 | $42.36 | $11.5M | — | View → |
| Jun 15, 2026 | Jun 16 1:18 AM | OrbiMed Genesis Master Fund, L.P. | Proposed Sale | 9,086 | $42.36 | $384.9K | — | View → |
| Jun 5, 2026 | Jun 9 8:49 PM | Lori Anne KunkelDirector | Sale | 10,000 | $34.54 | $345.4K | 51,884(D) | View → |
| Jun 5, 2026 | Jun 5 8:29 PM | Kunkel Lori Anne | Proposed Sale | 20,000 | $35.49 | $709.8K | — | View → |
| May 18, 2026 | May 20 8:18 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $39.79 | $199.0K | 25,000(D) | View → |
| May 18, 2026 | May 18 8:28 PM | Collins Helen Louise | Proposed Sale | 15,000 | $41.34 | $620.1K | — | View → |
| Apr 30, 2026 | Apr 30 8:17 PM | Lyssikatos Joseph P | Proposed Sale | 25,000 | $42.40 | $1.1M | — | View → |
| Apr 17, 2026 | Apr 22 12:40 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $47.67 | $238.4K | 25,000(D) | View → |
| Mar 31, 2026 | Mar 31 8:29 PM | Lyssikatos Joseph P | Proposed Sale | 25,000 | $36.59 | $914.8K | — | View → |
| Mar 31, 2026 | Mar 31 8:26 PM | ANDREW PHILLIPS | Proposed Sale | 26,035 | $38.55 | $1.0M | — | View → |
| Mar 25, 2026 | Mar 27 8:57 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 40,000 | $35.10 | $1.4M | 25,000(D) | View → |
| Mar 25, 2026 | Mar 25 8:29 PM | Collins Helen Louise | Proposed Sale | 45,000 | $31.15 | $1.4M | — | View → |
| Mar 24, 2026 | Mar 24 8:26 PM | Patel Anish | Proposed Sale | 100,000 | $30.81 | $3.1M | — | View → |
| Mar 17, 2026 | Mar 19 9:50 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $27.76 | $138.8K | 25,000(D) | View → |
| Mar 10, 2026 | Mar 11 9:32 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 10,129 | $30.19 | $305.8K | 25,000(D) | View → |
| Mar 9, 2026 | Mar 11 9:32 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 29,871 | $30.02 | $896.8K | 25,000(D) | View → |
| Mar 6, 2026 | Mar 10 10:15 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Sale | 10,000 | $29.58 | $295.8K | 51,000(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 12:57 AM | Scott J. GarlandDirector | Grant/Award | 1,427 | $27.16 | 1,427(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Mika K DerynckDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Jake BauerDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:55 AM | Rahul D. BallalDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:53 AM | Anish PatelCHIEF OPERATING OFFICER | Grant/Award | 120,000 | $27.16 | 120,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:52 AM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Grant/Award | 112,500 | $27.16 | 112,500(D) | View → |
| Feb 12, 2026 | Feb 18 12:49 AM | Benjamin HohlCHIEF FINANCIAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:47 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
← Previous
Page 2 of 2